AK

Anuradha Krishnamurthy

Physician · Roswell Park Comprehensive Cancer Center

Credentials: · · · · ·

History

Roswell Park Comprehensive Cancer Center
2023–Present

University of Pittsburgh
2019–2021
Internal Medicine
University of Colorado School of Medicine
2016–2019
Doctor of Medicine
2012–2016

Research

Bispecific antibodies for cancer therapy: A review
Review · Pharmacology & Therapeutics · 2018 · First of 2 authors · 162 citations
Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma
European Journal of Endocrinology · 2022 · 139 citations
Pembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysis
Clinical Epigenetics · 2022 · Last of 19 authors · 54 citations

JR
John Rhee
3 papers
AP
Amita Patnaik
2 papers
Antonio Jimeno
2 papers
JO
James Ohr
2 papers
Nathan Bahary
2 papers
SG
Steven Gore
2 papers
Wells Messersmith
2 papers
Aatur Singhi
1 paper
Adam Olson
1 paper
Adam Slivka
1 paper
Alessandro Paniccia
1 paper · 1 as a fellow
AD
Alexander Drilon
1 paper

Clinical trials

Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma
Principal investigator · Suspended · Phase 1
Roswell Park Cancer Institute
2026–2029
EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer
Principal investigator · Active not recruiting · Early phase 1
Roswell Park Cancer Institute
2023–2029
A Phase 2 Study of Pembrolizumab (MK-3475) in Combination With Azacitidine in Subjects With Chemo-refractory Metastatic Colorectal Cancer
Principal investigator · Completed · Phase 2
Anuradha Krishnamurthy
2015–2017
Study of ACR-2316 in Specific Advanced Solid Tumors
Site PI · Recruiting · Phase 1, Phase 2
Acrivon Therapeutics
2024–2027